Volume 86, Issue 3, 2022-3-1, Pages A1-e138

Articles in this issue:

1. Editorial Board 

2. Table of Contents 

3. Information for Readers 

4. JAAD Case Reports Article List 

5. Journal based CME Instructions and Information 

6. Melanoma: How and when to consider clinical diagnostic technologies 

7. Melanoma: An update on systemic therapies 

8. Sunk cost bias 

9. This month in JAAD: March 2022 

10. This Month in JAAD Case Reports: March 2022. Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2 

11. This month in JAAD International: March 2022: The psychological impact of acne scarring 

12. The neutrophil-to-lymphocyte ratio in cutaneous oncology: Simply elegant 

13. Epicardial adipose tissue volume is greater in men with severe psoriasis, implying an increased cardiovascular disease risk: A cross-sectional study 

14. Diagnosing muscle disease in a cohort of classic dermatomyositis patients seen at a rheumatologic dermatology outpatient clinic 

15. Scalp and serum profiling of frontal fibrosing alopecia reveals scalp immune and fibrosis dysregulation with no systemic involvement 

16. Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis 

17. Health-related quality of life and economic burden of prurigo nodularis 

18. Comparison of two-year treatment adherence, persistence, discontinuation, reinitiation, and switching between psoriasis patients treated with ixekizumab or secukinumab in real-world settings 

19. Disease burden, symptoms, and use of analgesics in patients with psoriasis with or without psoriatic arthritis: A cross-sectional study 

20. Cohort and nested case-control study of cutaneous squamous cell carcinoma in solid organ transplant recipients, by medication 

21. Difamilast ointment in adult patients with atopic dermatitis: A phase 3 randomized, double-blind, vehicle-controlled trial 

22. Neutrophil-to-lymphocyte ratio is associated with survival and sentinel lymph node positivity in invasive cutaneous squamous cell carcinoma: A retrospective study 

23. Basal cell carcinoma with bone invasion: A systematic review and pooled survival analysis 

24. Management of inadequate response and adverse effects to dupilumab in atopic dermatitis 

25. Assessing psoriasis severity: Psychometric validation of overall physician global assessment 

26. Gender discordance of genital examination experiences among dermatology residents and attendings 

27. Diagnostic performance of artificial intelligence for histologic melanoma recognition compared to 18 international expert pathologists 

28. Measurement and prediction of the severity of postinflammatory dyspigmentation after resolution of psoriatic plaques in patients treated with biologic therapy 

29. Trends in geographic and home program preferences in the dermatology residency match: A retrospective cohort analysis 

30. Discrimination between invasive and in situ melanomas using a convolutional neural network 

31. A cross-sectional study of YouTube videos on Mohs surgery: Quality of content and sentiment analysis 

32. Assessment of dermatologist-patient race and ethnicity concordance in the Medicare population 

33. Effective strategies to reduce pain during platelet-rich plasma scalp injections: A randomized split-scalp study 

34. Real-world disease burden and comorbidities of pediatric prurigo nodularis 

35. Improved performance and participation by dermatologists in the evolving merit-based incentive payment system: A cross-sectional analysis of 2018 data 

36. Association of type 2 diabetes with central centrifugal cicatricial alopecia: A follow-up study 

37. Characteristics, evaluation, and outcomes of patients with squamous cell carcinoma lacking histologic continuity to the epidermis 

38. Effect of older age on complications and mortality in inpatients with Stevens-Johnson syndrome or toxic epidermal necrolysis 

39. Response to systemic therapies in granulomatous cheilitis: Retrospective multicenter series of 61 patients 

40. Operationally balancing resident education and patient waiting time in an outpatient academic setting 

41. Evaluation of dermatologist performance in the 2017 merit-based incentive payment system based on patient social factors 

42. Clinical and psychosocial factors affecting work productivity among patients with hidradenitis suppurativa: A cluster analytical investigation 

43. Dapsone as corticosteroid-sparing therapy for Sweet syndrome 

44. Using cluster analysis to identify dermatologist and internist prescribing phenotypes for acne management 

45. Identifying sociodemographic factors associated with hospitalization following primary excision of cutaneous melanoma 

46. Alopecia areata flare patterns in children and young adults while on systemic tofacitinib 

47. Characteristics of dermatology clinical trials 2007-2018: Insights from a systematic analysis of ClinicalTrials.gov 

48. Pegylated liposomal doxorubicin-induced hand-foot syndrome predicted by serum metabolomic profiling and prevented by calcium dobesilate 

49. The effects of neurotoxin and soft tissue fillers on gender perception in transgender individuals: A pilot prospective survey-based study 

50. Lasers as an adjuvant for vulvar lichen sclerosus: A systematic review and meta-analysis 

51. Factors associated with perceived stress in patients with vitiligo in the ComPaRe e-cohort 

52. Gender representation in the authorship of dermatology publications 

53. Skin cancer screening using total body photography and digital dermoscopy: A pilot study among Florida firefighters 

54. Age- and sex-adjusted prevalence estimates among adults with psoriasis in the United States 

55. Representation of skin color in dermatology-related Google image searches 

56. Development of psoriasis during treatment with dupilumab: A systematic review 

57. Association between psoriasis and asthma among United States adults in the 2009-2014 National Health and Nutrition Examination Survey 

58. The dermatologist's role in tattoo removal for incarcerated individuals 

59. Management of refractory prurigo nodules with Dermabond in pediatric patients 

60. Disposable syringe for chemical cautery 

61. Tethered epidermal edges in Mohs micrographic surgery: A cheese pizza analogy and solution 

62. Transforming the lower eyelid longitudinal incision direction to conceal the closure line: Longitudinal incision horizontal closure 

63. Syringe tube as ampoule opener: A safe, simple, and effective tool in dermatologic surgery 

64. Fully use the pulley 

65. Using ink to highlight follicular ostia when performing trichoscopy 

66. Reply to Letter to the Editor regarding: “Basal cell carcinoma: Management of advanced or metastatic cancer with checkpoint inhibitors and concurrent paradoxical development of new superficial tumors” 

67. Reply to “Effective therapy for advanced basal cell carcinoma” 

68. The significance of the Lattice-System Physician's Global Assessment as a research tool for measuring mild-to-moderate psoriasis 

69. Lack of skin of color in Google image searches may reflect under-representation in all educational resources 

70. Comment on: Development of psoriasis during treatment with dupilumab: A systematic review 

71. Correspondence to “Association between psoriasis and asthma among United States adults in the 2009-2014 national health and nutrition examination survey” 

72. Reply to “Correspondence to ‘Association between psoriasis and asthma among United States adults in the 2009-2014 National Health and Nutrition Examination Survey’” 

73. The call to action to increase racial and ethnic diversity in dermatology: A retrospective, cross-sectional study to monitor progress 

74. The close resemblance between patients with severe alopecia areata and those with cancer: What hair tells us about wellness or grave illness 

75. From the Cochrane Library: Probiotics for treating eczema 

76. Accessibility of direct-to-consumer teledermatology to underserved populations 

77. Reply to: “Accessibility of direct-to-consumer teledermatology to underserved populations” 

78. A novel topical treatment for plaque psoriasis: Benvitimod/tapinarof